staceywhite, Author at European Medical Journal - Page 32 of 195

31 Oct 2024

Tackling Infectious Diseases

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.

31 Oct 2024

Under the Lens: Progression of Diabetic Retinopathy and the Impact of Fenofibrate

With an increasing prevalence of diabetic retinopathy, a cause of vision impairment and blindness in those with diabetes, there is a need…

Unravelling HER2+ Breast Cancer

A highly engaging infographic providing information on the incidence, diagnosis and treatment options for HER2+ breast cancer. It touches…

ER+/HER2- Metastatic Breast Cancer – Treatment after ET + CDK4/6i

Over 70% of breast cancers are ER+/HER2-, for which the backbone of treatment is ET.1-3 Advanced breast cancer (aBC) can be considered to…

Predisposition, Clinical Characteristics and Management of Immune Checkpoint Inhibitor-Induced Nephritis

Immune checkpoint inhibitors (ICI) use can lead to an array of immune-related adverse events (irAE). Nephritis is considered to be…

Cancer Vaccines

An insightful infographic summarising the latest in cancer vaccines research. Information provided summarises the prevalence of certain…

Patient-Centred Therapies for mNSCLC

The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a result of…

ESMO 2024 Abstract Highlights

The following abstracts showcase the top cutting-edge research presented at the European Society for Medical Oncology (ESMO) Congress 2024…

Synergy of Tumour and Liquid Biopsy

The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the goal of…

Therapeutic Advances in Gastrointestinal Cancers: Immuno-oncology and Beyond

At the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain, the latest advancements in immunotherapy for…